Success Stories
Driving Innovation, Building Partnerships, Delivering Results
As a trusted leader in medical device, cosmetics, and pharmaceutical registration across Saudi Arabia, UniFusion is proud to share our milestones, collaborations, and industry impact. Discover how we’re shaping compliance, accelerating innovation, and connecting with global MedTech pioneers.
MDMA Approval for Morningcon Soft Contact Lens
22.01.2026
UniFusion B.S.C is proud to announce the successful issuance of MDMA approval for the Morningcon Soft Contact Lens, a Class C ophthalmic medical device intended for the correction of myopia in the Saudi Arabian market.
Product Details
Manufacturer: Gansu Constar Technology Group Co., Ltd.
Product Name: Morningcon Soft Contact Lens
Classification: Class C Medical Device
Morningcon Soft Contact Lenses are designed to correct refractive errors by modifying the eye’s refractive power, enabling light to focus accurately on the retina. This mechanism enhances visual acuity for individuals with myopia while ensuring comfort, safety, and biocompatibility for regular use.
This regulatory approval marks a significant milestone, reflecting UniFusion B.S.C’s expertise in navigating complex regulatory pathways and its commitment to delivering high-quality, compliant ophthalmic solutions that meet international safety and performance standards.
UniFusion B.S.C remains dedicated to supporting the introduction of innovative medical technologies into the Saudi market and enabling access to reliable vision correction solutions.
Unifusion BSC Achieves MDMA Approval for the World’s First Foldable Capsular Vitreous Body (FCVB)
27.12.2025
Unifusion BSC has achieved a major regulatory milestone by obtaining SFDA Marketing Authorization for the Foldable Capsular Vitreous Body (FCVB), manufactured by Guangzhou Vesber Biotechnology Co., Ltd. The FCVB is the world’s first safe and effective artificial vitreous substitute designed to closely mimic the natural human vitreous body. This innovative technology provides 360-degree retinal support, prevents silicone oil-related complications, preserves intraocular function, and offers a critical new treatment option for patients with severe ocular trauma, silicone oil-dependent eyes, and complex retinal detachments. The approval reflects Unifusion BSC’s commitment to advancing healthcare innovation in the Kingdom in line with Saudi Vision 2030.
partnership with United Imaging
29.01.2025
We’re pleased to announce our partnership with United Imaging Healthcare (UIH), a global leader in advanced medical imaging. Operating in over 75 countries, UIH has delivered more than 30,000 high-performance systems, supporting healthcare providers with innovative solutions. Through this partnership, UniFusion B.S.C will facilitate UIH’s regulatory compliance and market access in Saudi Arabia, strengthening our mission to bring world-class medical technologies to the region.